JavaScript is disabled in your browser. Please enable JavaScript to view this website.

Connecting Molecular, Spatial and Functional Biology

connecting-molecular

Biological complexity spans multiple levels that a single measurement technology cannot capture. A molecular signal may identify what has changed, but often doesn’t identify where that change occurs, which cells are involved or whether it alters biological function. Biomarker discovery, therefore, demands a multi-modal approach that links molecular composition, spatial context and functional outcomes to provide a more holistic view of disease biology.

Why promising biomarker signals can lose momentum

Achieving the needed level of context requires researchers to address several interconnected challenges:

Key Challenge
Description
Impact on Analysis
Data fragmentation
Disparate datasets (omics, imaging, functional assays) are generated in silos and difficult to align
Limits cross-modal data integration and reduces the ability to derive unified biological insights
Spatial-to-molecular disconnect
Linking tissue-level and cellular observations to underlying molecular identity remains technically complex
Constrains interpretation of biomarker localization and biological relevance
Throughput vs. depth tradeoffs
High-content data acquisition often reduces scalability and throughput
Slows large-scale studies and limits statistical power in biomarker discovery
Reproducibility across modalities
Variability in sample prep, assay conditions and analysis pipelines can limit comparability
Reduces confidence in multi-platform validation and translational applicability

Connect biomarker signals to biological meaning

Addressing these challenges requires an interconnected, multi-modal approach that spans molecular, spatial and functional insights across workflows. Each layer answers a different question and becomes more informative when interpreted with the others. These capabilities demonstrate how this framework can be applied to support multi-modal evidence generation.

genomic-resolution

Genomic Resolution - Targeted NGS and custom oligos

IDT NGS solutions, including xGen and Archer™ NGS solutions, support genomic characterization across both broad and focused biomarker research applications. xGen solutions enable flexible target enrichment, while Archer™ solutions support targeted DNA/RNA analysis, including the identification of genomic alterations such as SNVs, indels, CNVs, fusions and expression changes in research samples.

biological-specificity

Biological Specificity - Multi-platform validation reagents

Well-characterized antibodies and multiplex immunoassays perform consistently across imaging, proteomics and functional assays, ensuring reproducible, biologically concordant results.

Functional Insight

Functional Insight - Cell-based, high-content imaging

ImageXpress® HCS with IN Carta® analysis quantifies cellular phenotypes at scale, tying molecular and spatial findings to measurable functional outcomes.

molecular-depth

Molecular Depth - High-sensitivity mass spectrometry

The ZenoTOF 8600 system and SCIEX 7500+ system deliver sensitive, reproducible biomolecule identification and quantification for both discovery and targeted work, anchoring analyses with confident molecular characterization

spatial-context

Spatial Context - 2D and 3D Multiplexed tissue imaging

Cell DIVE™ imaging, SpectraPlex™ 3D multiplexing and laser microdissection on the LMD provide complementary spatial biology capabilities, from high-plex tissue imaging to single-cell collection, linking spatial context with molecular and downstream omics data.

What a connected biomarker workflow looks like

  1. Start with the intended use: Define the biological question, patient population, specimen type and the decision the biomarker is meant to support, so the objective determines which modalities are needed
  2. Align experimental design: Coordinate sample collection, processing and study design so molecular, spatial and functional measurements can be compared reliably
  3. Identify convergent evidence: Use complementary molecular, spatial and functional measurements to challenge and refine one another, reduce uncertainty and prioritize candidates supported across modalities rather than solely by statistical significance in a single dataset
  4. Validate orthogonally: Confirm candidates using independent methods, samples and cohorts to test analytical performance, biological reproducibility and feasibility
  5. Plan for translation early: Consider assay scalability, sample requirements, turnaround time and the proposed context of use before advancing a candidate

From disconnected data to translational insight

The value of a connected biomarker ecosystem lies in linking molecular change, spatial context and functional consequence into a coherent body of evidence. This connection can help researchers prioritize more meaningful candidates, reduce uncertainty and create a stronger path to biomarker application.

Explore how a connected biomarker strategy can help advance promising candidates with greater confidence.

Biomarker Ebook

Translational-Ready Biomarkers Start with Connected Workflows

Download Biomarker ebook